Resolute Integrity Coronary Stent Systems
FDA premarket approval P110013/S087 · decided 2018-03-15
Approval details
- PMA number
- P110013
- Supplement
- S087
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Resolute Integrity Coronary Stent Systems
- Generic name
- Coronary drug-eluting stent
- Applicant
- Medtronic Vascular
- Date received
- 2017-12-18
- Decision date
- 2018-03-15
- Days to decision
- 87 days
- Decision code
- APPR
- Product code
- NIQ
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Rosa, CA
- Statement
- Approval to introduce changes to the annual stability study design for the Resolute Onyx Coronary Stent System and Resolute Integrity Coronary Stent System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.